Historical record - last NADAC effective date: 9/18/2024
This NDC is on FDA's drug shortage list (posted Oct 31, 2017)
Product Information
MORPHINE 2 MG/ML CARPUJECT is a generic product labeled by Hospira Inc., priced at $1.8340 per ML under NDC 00409189001. Its NADAC has been published 56 times since Aug 21, 2024.
FDA first approved this application on Nov 14, 2011. Its Orange Book therapeutic-equivalence code is AP.
Strength
2 mg/mL
Manufacturer
Hospira Inc.NDC
00409189001
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Effective Date
9/18/2024
Active Ingredients
MORPHINE SULFATEApproval Type
New Drug (NDA)
FDA Application
NDA202515FDA Approved
11/14/2011
TE Code
AP
On Market Since
8/23/2012
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE 2 MG/ML CARPUJECT has been published 56 times since Aug 21, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.8340 per ML |
|---|---|
| All-time high | $1.8340 (Sep 10, 2025) |
| All-time low | $1.8340 (Aug 21, 2024) |
| Median price | $1.8340 |
| Average price | $1.8340 |
| Largest weekly change | 0.0% (Aug 28, 2024) |
| Weeks tracked | 56 |
| Tracking since | Aug 21, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Sep 10, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the MORPHINE SULFATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hospira Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
MORPHINE SULFATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MORPHINE 2 MG/ML CARPUJECT?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE 2 MG/ML CARPUJECT, manufactured by Hospira Inc., is $1.8340 per ML (NDC 00409189001), effective Sep 10, 2025.
How has the price of MORPHINE 2 MG/ML CARPUJECT changed over time?
Over the history we have for it, the NADAC for MORPHINE 2 MG/ML CARPUJECT has held within roughly two percent of its current level. It has been tracked across 56 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for MORPHINE 2 MG/ML CARPUJECT?
Since Aug 21, 2024, the NADAC for MORPHINE 2 MG/ML CARPUJECT has ranged from a low of $1.8340 (Aug 21, 2024) to a high of $1.8340 (Sep 10, 2025), with a median of $1.8340 per ML.
Are there cheaper alternatives to MORPHINE 2 MG/ML CARPUJECT?
No other NADAC-published product currently shares the active ingredient and strength of MORPHINE 2 MG/ML CARPUJECT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MORPHINE 2 MG/ML CARPUJECT?
MORPHINE 2 MG/ML CARPUJECT (NDC 00409189001) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Is MORPHINE 2 MG/ML CARPUJECT in shortage?
Yes — NDC 00409189001 is currently listed in FDA's drug shortage database (posted Oct 31, 2017).